the obligation to collect specific pharmacovigilance data additional to the data listed in Article 73(2) and to carry out post-marketing surveillance studies in accordance with Article 76(3);
an oibleagáid chun sonraí cógas-aireachais sonracha a bhailiú de bhreis ar na sonraí a liostaítear in Airteagal 73(2) agus chun staidéir iarmhargaíochta a dhéanamh i gcomhréir le hAirteagal 76(3);